Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bone is a specialized mineralized connective tissue composed of a dense extracellular matrix predominantly consisting of type I collagen and hydroxyapatite crystals, which together provide mechanical strength and rigidity[1][3][7]. It contains four main cell types: osteoblasts (bone-forming), osteocytes (mature, matrix-embedded), osteoclasts (bone-resorbing), and bone lining cells, all coordinating bone remodeling and homeostasis[1][7]. Bone serves structural, protective, metabolic, and hematopoietic functions, and its dynamic remodeling is tightly regulated by local and systemic factors, including various hormones, cytokines, and growth factors[1][7][9]. In clinical medicine, bone is a tissue system rather than a molecular or protein target; therapies for bone diseases commonly target molecular mediators (such as RANKL, parathyroid hormone receptor, sclerostin) or pathways involved in bone cell activity and matrix regulation, rather than "bone" as a discrete target in the sense of a single molecular entity[2][4].
Bisphosphonates: Inhibit osteoclast-mediated bone resorption Denosumab: RANKL inhibitor, reduces osteoclast formation/function Parathyroid hormone analogs: Intermittent stimulation of bone formation (anabolic effect) Romosozumab: Sclerostin inhibitor, increases bone formation and reduces resorption Calcitonin: Directly inhibits osteoclast activity
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bone.